The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 InfectionArticle Published on 2022-10-052022-11-15 Journal: Viruses [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] acute respiratory syndrome antibody antibody assay Antibody test assays calculated Clinical practice coronavirus detection diagnostic sensitivity different time point ELISA epidemiological studies evaluate IgG IgG test nucleocapsid PCR positivity performance performed Point positive Predictive RBD RBD IgG Receptor binding Receptor binding domain reduced remained S1/S2 SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 PCR SARS-CoV-2 RBD SARS-CoV-2 spike sensitivity sera specificity spike tested time [DOI] 10.3390/v14102196 PMC 바로가기
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccinationArticle Published on 2022-10-042022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] administration Adverse adverse effect anti-RBD Anti-RBD IgG antibody Antibody Response Arm ARMS binding domain BNT162b2 ChAdOx1 ChAdOx1 nCoV-19 comparable Concentration conducted CoronaVac country COVID COVID vaccine COVID-19 COVID-19 vaccine COVID-19 vaccines dose Effect Effects eligible exploratory first dose fractional dose vaccination Frame Heterologous heterologous regimen highest homologous IgG immunogenic implication IMPROVE Intradermal intradermal vaccination intradermal vaccine intramuscular intramuscular vaccination less lowest of BNT162b2 Omicron variant pilot study Population Protein regimen regimens reported Safe Safety SARS-CoV-2 variants second dose spike Standard dose Study participants systemic adverse reaction T-cell Response the SARS-CoV-2 undetectable vaccination Vaccine vaccine immunogenicity vaccine safety [DOI] 10.3389/fimmu.2022.1010835 PMC 바로가기
SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participantsArticle Published on 2022-10-032022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, [키워드] addition adenovirus vaccine Analysis anti-SARS-CoV-2 IgG Anti-spike AstraZeneca BBIBP-CorV Blood Breastfeeding breastmilk ChAdOx1-S children Cohort convalescent COVID-19 COVID-19 vaccine cross-sectional decrease eligible evaluated IgA IgA level IgA response IgG IgG level immune response inactivated Infection information lactating lactating women mother mRNA naïve Newborn no significant difference Oxford participant passive immunity positive receive receiving recent SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine SARS-CoV-2-specific antibody second dose serum serum sample shown significantly higher Sinopharm Sputnik V vaccination Vaccine vaccine platform Vaccines women [DOI] 10.3389/fimmu.2022.909995 PMC 바로가기
Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in the Mozambican Population: A Cross-Sectional Serologic Study in 3 Cities, July-August 2020Article Published on 2022-10-032022-11-15 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI 95% confidence interval acute respiratory syndrome adjusted African age anti-SARS-CoV-2 antibody city conducted coronavirus coronavirus 2 country COVID-19 cross-sectional exposure to General population group groups higher-risk occupational groups IgG IgM Immunoglobulin Maputo Mozambique pandemic Participants point-of-care Prevalence Public health intervention Randomly ranged Rapid test respiratory respond SARS-CoV-2 selected Sensitivity and specificity serologic Seroprevalence Serosurvey Sex tested Transmission Variation were measured [DOI] 10.1093/cid/ciac516 PMC 바로가기
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulins using chemiluminescence immunoassay and its correlation with neutralizing antibodiesArticle Published on 2022-10-022022-11-15 Journal: Virus research [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] acute respiratory syndrome analyzed anti-SARS-CoV-2 antibodies antibody Asymptomatic asymptomatic individual Asymptomatic individuals AUC can be used chemiluminescence chemiluminescence immunoassay chemiluminescent immunoassay clinical comparable coronavirus correlation enrolled evaluated group IgG immune Immunoglobulin in both groups microneutralization NAb NAbs negative RT-PCR neutralization activity neutralization titer Neutralizing antibodies neutralizing antibody participant positive positive serology predict Previously symptomatic Protective protective immunity random reactive RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 patients screened serology Significant significantly higher symptomatic symptomatic individual symptomatic individuals symptomatic patient Symptomatic patients total Ig USA were measured [DOI] 10.1016/j.virusres.2022.198852 PMC 바로가기
Neutralizing antibody responses to SARS-CoV-2: A population based seroepidemiological analysisArticle Published on 2022-10-012022-11-15 Journal: Indian journal of medical microbiology [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] Analysis anti-SARS-CoV-2 IgG Anti-SARS-CoV-2 neutralizing antibody Antibody Response correlated COVID-19 detectable General population Genscript IgG Neutralizing neutralizing antibody neutralizing capacity random ranged Sample SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 neutralizing antibodies SARS-CoV-2 neutralizing antibody selected seropositive sample sVNT USA vaccination virus neutralization test [DOI] 10.1016/j.ijmmb.2022.07.009 PMC 바로가기
SARS-CoV-2 spike IgG titres up to 137 days following Comirnaty mRNA COVID-19 vaccination, Israel, February to May 2021Article Published on 2022-10-012022-11-15 Journal: Eurosurveillance [Category] COVID19(2023년), SARS, 진단, [키워드] antibody antibody level baseline characteristics body mass cardiovascular disease Chronic kidney disease chronic obstructive Comorbidity Concentration conducted congestive heart failure coronavirus COVID-19 COVID-19 vaccination COVID-19 vaccine cut-off diabete dose Factor female first dose geometric mean GFR glomerular filtration rate GMC GMCs IgG IgG antibodies IgG antibody Immunosuppression Infection Inflammatory bowel disease levels of antibody male mRNA Patient peaked pulmonary disease remained repeated reported resource retrospective cohort study SARS-CoV-2 SARS-CoV-2 spike serological serology solid malignancy the antibody the SARS-CoV-2 titre vaccination were used [DOI] 10.2807/1560-7917.ES.2022.27.40.2100703 PMC 바로가기
Memory B cells and serum immunoglobulins are associated with disease severity and mortality in patients with COVID-19Article Published on 2022-10-012022-11-15 Journal: Postgraduate medical journal [Category] 진단, [키워드] addition association B cell B cells B lymphocyte B lymphocytes Cell Cell-mediated immunity COVID-19 COVID-19 severity Deceased disease severity evaluate examined Factors female general medicine IgA IgG Immunoglobulin immunology independent risk factor laboratory-confirmed median median age memory B cell memory B cells Mortality parameter Patient patients with COVID-19 prognosis of patient recovered patient recruited respiratory infections retrospective cohort serum serum immunoglobulin serum immunoglobulin levels shown significant negative correlation significantly lower subset Survivors the patient Virology was used were measured with COVID-19 [DOI] 10.1136/postgradmedj-2021-140540 PMC 바로가기
Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysisArticle Published on 2022-10-012022-11-15 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 진단, [키워드] adjusted adverse effect age Analysis Anti-spike binding antibody unit binding domain boost Combination Complete Concentration COVID COVID-19 doses enrolled evaluated event female Frequency Gam-COVID-Vac Gender Heterologous Heterologous scheme homologous humoral humoral immune response IgG immunization increase individual induce interquartile range IQR Linear model median Mild moderate Moderna mRNA-1273 participant RBD real-world data required SARS-CoV-2 Serological assay Seven significantly significantly higher vaccination Vaccine [DOI] 10.1016/j.cmi.2022.05.009 PMC 바로가기
Pre-vaccination immune response to COVID-19 in a population in Northeast PortugalArticle Published on 2022-10-012022-11-15 Journal: Irish Journal of Medical Science [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome age Analysis antibody application Asymptomatic coronavirus COVID-19 diagnosed Diagnosis exhibited group highest IgG IgM IgM and IgG immune response Immunity immunization individuals initial Laboratory median value participant Participants Patient PCR PCR diagnosis peaked Portugal Protein reported responders RT-PCR SARS-CoV-2 Seronegativity seropositive significant decrease statistically significant study population Symptom symptomatic vaccination [DOI] 10.1007/s11845-021-02799-6 PMC 바로가기